Unfavorable effects of sodium-glucose cotransporter 2 (SGLT2) inhibitors on the skeletal system of nondiabetic rats

Sodium-glucose cotransporter 2 (SGLT2) inhibitors are a new class of antidiabetic drugs, acting by inhibiting the reabsorption of glucose in the kidneys. They turned out to improve cardiovascular and renal outcomes not only in patients with type 2 diabetes but also in nondiabetic patients. At presen...

Full description

Bibliographic Details
Main Authors: Piotr Londzin, Agata Brudnowska, Katarzyna Kurkowska, Katarzyna Wilk, Karolina Olszewska, Łukasz Ziembiński, Aleksandra Janas, Urszula Cegieła, Joanna Folwarczna
Format: Article
Language:English
Published: Elsevier 2022-11-01
Series:Biomedicine & Pharmacotherapy
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S075333222201068X